GB2338186A — Compositions for treating gastric and oesophageal complaints
Assigned to Reckitt Benckiser Healthcare UK Ltd · Expires 1999-12-15 · 26y expired
What this patent protects
Formulations for the treatment of gastro-oesophageal reflux disease which include a carrier vehicle and a gastroprotective agent. The carrier vehicle is either capable of forming a floating barrier layer on contact with gastric acid, or of forming a bioadhesive film before contac…
USPTO Abstract
Formulations for the treatment of gastro-oesophageal reflux disease which include a carrier vehicle and a gastroprotective agent. The carrier vehicle is either capable of forming a floating barrier layer on contact with gastric acid, or of forming a bioadhesive film before contact with gastric acid occurs, so as to protect gastric mucosa from irritation by the gastric acid. The gastroprotective agents include capsaicin, zingerone curcumin, piperine, resiniferatoxin or crude extracts of capsicum, black pepper, cayenne pepper, paprika, mace, mustard, ginger turmeric or papaya seeds.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.